The combined mortality rate (3 and 7 days after stroke, prior to sacrifice) due to delayed tPA treatment was decreased by 46% when G-CSF was administered to rats in conjunction with tPA (Figure 2C). The gene discussed is CSF3; the disease is Stroke.